Abcalis Multiclonal Recombinant Secondary Antibodies
Multiclonals are recombinant secondary antibodies developed by AdipoGen’s innovative partner Abcalis. They consist of defined mixtures of carefully selected individual recombinant monoclonal antibodies, recognising different epitopes on all four different subclasses of human IgG. Their respective epitope binding sites do not compete with each other, therefore amplifying signal strengths.
Multiclonals are useful for secondary antibody applications where a polyclonal antibody would traditionally be used and are able to provide the specificity and reproducibility only available from a recombinant antibody, making them a suitable alternative for diagnostic and research applications.
Phone: 02 9698 2022
Biosensis MAP2 antibodies
Biosensis's validated MAP2 antibodies are designed to help users identify MAP2, whether they...
Bio-Rad Laboratories Celselect Slides validated antibodies for rare cell and CTC enumeration
The antibodies are specific to CTC surface markers to enable the sensitive and specific...
Microbiologics UV-BioTAG QC microorganisms for quality control testing
UV-BioTAG, a line of reference strains containing green fluorescent protein (GFP) markers, makes...